We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+26.18%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$280B
AUM Growth
+$58B
Cap. Flow
-$9.91B
Cap. Flow %
-3.53%
Top 10 Hldgs %
32.38%
Holding
11,014
New
1,506
Increased
4,384
Reduced
3,586
Closed
1,324

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$861M
2
AAPL icon
Apple
AAPL
+$417M
3
JPM icon
JPMorgan Chase
JPM
+$350M
4
TMUS icon
T-Mobile US
TMUS
+$337M
5
AON icon
Aon
AON
+$296M

Sector Composition

Rank Sector Weight
1 Healthcare 3.4%
2 Technology 3.32%
3 Consumer Discretionary 2.87%
4 Financials 2.84%
5 Industrials 2.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNWK
9151
CALL
DELISTED
RealNetworks Inc
RNWK
$48K ﹤0.01%
+36,700
New +$40.2K
ABUS icon
9152
CALL
Arbutus Biopharma
ABUS
$857M
$47K ﹤0.01%
+25,600
New +$41.9K
BWEN icon
9153
Broadwind
BWEN
$93.6M
$47K ﹤0.01%
+12,653
New +$28.5K
DBVT
9154
CALL
DBV Technologies
DBVT
$799M
$47K ﹤0.01%
1,080
-1,220
-53% -$62.3K
GALT icon
9155
Galectin Therapeutics
GALT
$196M
$47K ﹤0.01%
15,383
-36,220
-70% -$91.1K
TDAY
9156
CALL
USA Today Co
TDAY
$1.27B
$47K ﹤0.01%
34,200
-8,800
-20% -$11.6K
KLXE icon
9157
CALL
KLX Energy Services
KLXE
$45M
$47K ﹤0.01%
4,340
+1,580
+57% +$12.6K
MRKR icon
9158
CALL
Marker Therapeutics
MRKR
$18.8M
$47K ﹤0.01%
2,280
+1,120
+97% +$24.5K
SDEV
9159
Stablecoin Development Corp
SDEV
$58M
$47K ﹤0.01%
+7
New +$39.4K
ADAM
9160
CALL
Adamas Trust
ADAM
$815M
$47K ﹤0.01%
4,475
-3,275
-42% -$28.7K
SJT
9161
CALL
San Juan Basin Royalty Trust
SJT
$117M
$47K ﹤0.01%
20,800
-4,800
-19% -$12.1K
TTI icon
9162
TETRA Technologies
TTI
$1.14B
$47K ﹤0.01%
89,212
+19,454
+28% +$7.67K
ENSV
9163
DELISTED
Enservco Corp.
ENSV
$47K ﹤0.01%
18,150
+5,890
+48% +$15.1K
AXU
9164
PUT
DELISTED
Alexco Resource Corp
AXU
$47K ﹤0.01%
20,800
-2,400
-10% -$4.44K
ESTE
9165
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$47K ﹤0.01%
16,396
-16,632
-50% -$40.6K
CHRD icon
9166
Chord Energy
CHRD
$7.9B
$46K ﹤0.01%
61,163
-3,370,603
-98% -$2.18M
KLXE icon
9167
KLX Energy Services
KLXE
$45M
$46K ﹤0.01%
+4,319
New +$34.4K
UEC icon
9168
PUT
Uranium Energy
UEC
$4.75B
$46K ﹤0.01%
52,100
+1,900
+4% +$1.84K
BEST
9169
CALL
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$46K ﹤0.01%
535
-925
-63% -$95K
YGYI
9170
CALL
DELISTED
Youngevity International, Inc Common Stock
YGYI
$46K ﹤0.01%
+32,300
New +$50.1K
ROSE
9171
DELISTED
Rosehill Resources Inc. Class A
ROSE
$46K ﹤0.01%
63,383
+35,055
+124% +$16.9K
ALDX icon
9172
PUT
Aldeyra Therapeutics
ALDX
$92.9M
$45K ﹤0.01%
+10,700
New +$39.1K
SUP
9173
DELISTED
Superior Industries International
SUP
$45K ﹤0.01%
26,310
+15,736
+149% +$22.5K
ENZ
9174
PUT
DELISTED
Enzo Biochem, Inc.
ENZ
$45K ﹤0.01%
20,300
+3,200
+19% +$8.23K
TCS
9175
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$45K ﹤0.01%
934
-973
-51% -$37.5K

Similar funds

Citadel Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Citadel Advisors held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in Becton Dickinson worth $266M.

  • Citadel Advisors's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
  • Citadel Advisors added most to Amazon in Q2 2020, an estimated $861M increase.
  • Citadel Advisors's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
  • Citadel Advisors fully exited Allergan plc in Q2 2020, selling an estimated $603M.
  • Citadel Advisors's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
  • Citadel Advisors opened 1,506 new positions and closed 1,324 in Q2 2020.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $280B.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.